QuantLogix Private Company Profile

←Back to list

ArsenalBio

Developer of cellular drug discovery tools designed to provide medicines for cancer treatment.
Drug Discovery 📍 South San Francisco, CA Founded 2018
Current Valuation
$1.9B
as of 2024-Q3
UNICORN
Developer of cellular drug discovery tools designed to provide medicines for cancer treatment.

Company Profile

Founded
2018
HQ
South San Francisco, CA
Employees
216
Total Raised
$631M
Last Round
Series C — $325M (Sep 2024)
IPO Status
private

Fundraising Status

Series C · $325M · 1y 9mo ago
privateTotal raised $631M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series C$325MSep 2024—$1.9B
Artificial IntelligenceBiotechnologyCloud Computing
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q3. Refreshed quarterly.